Actively targeting solid tumours with thermoresponsive drug delivery systems that respond to mild hyperthermia

Area of Science:

• Biomedical Engineering
• Materials Science
• Oncology

Background:

• Active targeting strategies for chemotherapy often show limited efficacy due to reliance on subtle expression differences between tumor and healthy tissues.
• Drug delivery systems that exploit thermoresponsive behavior offer a method for spatially and temporally controlled drug delivery within tumor tissue.
• Mild hyperthermia (39-43°C) can be used to trigger the accumulation and/or release of chemotherapeutic agents.

Purpose of the Study:

• To review materials and strategies for thermoresponsive drug delivery systems.
• To discuss the combined application of hyperthermia and chemotherapy for primary tumor control.
• To highlight systems tuned for physiological temperature ranges in vivo.

Main Methods:

• Review of scientific literature on thermoresponsive materials for drug delivery.
• Analysis of strategies for controlling drug release using mild hyperthermia.
• Evaluation of in vivo performance of thermoresponsive systems.

Main Results:

• Thermoresponsive materials offer a promising approach for targeted chemotherapy.
• Mild hyperthermia provides a controllable trigger for drug release in the 39-43°C range.
• Few systems have been optimized for precise in vivo response within the physiological temperature window.

Conclusions:

• Thermoresponsive drug delivery systems combined with hyperthermia represent a significant advancement in targeted cancer therapy.
• Further research is needed to optimize these systems for reliable in vivo performance.
• This approach has the potential to improve treatment outcomes by minimizing systemic toxicity.